Literature DB >> 30894477

An Immunodominant and Conserved B-Cell Epitope in the Envelope of Simian Foamy Virus Recognized by Humans Infected with Zoonotic Strains from Apes.

Caroline Lambert1,2,3, Damien Batalie1,2, Thomas Montange1,2, Edouard Betsem1,2,4, Augustin Mouinga-Ondeme5, Richard Njouom6, Antoine Gessain1,2, Florence Buseyne7,2.   

Abstract

Cross-species transmission of simian foamy viruses (SFVs) from nonhuman primates (NHPs) to humans is currently ongoing. These zoonotic retroviruses establish lifelong persistent infection in their human hosts. SFV are apparently nonpathogenic in vivo, with ubiquitous in vitro tropism. Here, we aimed to identify envelope B-cell epitopes that are recognized following a zoonotic SFV infection. We screened a library of 169 peptides covering the external portion of the envelope from the prototype foamy virus (SFVpsc_huHSRV.13) for recognition by samples from 52 Central African hunters (16 uninfected and 36 infected with chimpanzee, gorilla, or Cercopithecus SFV). We demonstrate the specific recognition of peptide N96-V110 located in the leader peptide, gp18LP Forty-three variant peptides with truncations, alanine substitutions, or amino acid changes found in other SFV species were tested. We mapped the epitope between positions 98 and 108 and defined six amino acids essential for recognition. Most plasma samples from SFV-infected humans cross-reacted with sequences from apes and Old World monkey SFV species. The magnitude of binding to peptide N96-V110 was significantly higher for samples of individuals infected with a chimpanzee or gorilla SFV than those infected with a Cercopithecus SFV. In conclusion, we have been the first to define an immunodominant B-cell epitope recognized by humans following zoonotic SFV infection.IMPORTANCE Foamy viruses are the oldest known retroviruses and have been mostly described to be nonpathogenic in their natural animal hosts. SFVs can be transmitted to humans, in whom they establish persistent infection, like the simian lenti- and deltaviruses that led to the emergence of two major human pathogens, human immunodeficiency virus type 1 and human T-lymphotropic virus type 1. This is the first identification of an SFV-specific B-cell epitope recognized by human plasma samples. The immunodominant epitope lies in gp18LP, probably at the base of the envelope trimers. The NHP species the most genetically related to humans transmitted SFV strains that induced the strongest antibody responses. Importantly, this epitope is well conserved across SFV species that infect African and Asian NHPs.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  antibody; emergence; retrovirus; zoonotic infections

Mesh:

Substances:

Year:  2019        PMID: 30894477      PMCID: PMC6532072          DOI: 10.1128/JVI.00068-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  The intact retroviral Env glycoprotein of human foamy virus is a trimer.

Authors:  T Wilk; F de Haas; A Wagner; T Rutten; S Fuller; R M Flügel; M Löchelt
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Phylogeny and geography predict pathogen community similarity in wild primates and humans.

Authors:  T Jonathan Davies; Amy B Pedersen
Journal:  Proc Biol Sci       Date:  2008-07-22       Impact factor: 5.349

3.  Mucosal and systemic antibody responses in humans infected with simian foamy virus.

Authors:  James E Cummins; Roumiana S Boneva; William M Switzer; Logan L Christensen; Paul Sandstrom; Walid Heneine; Louisa E Chapman; Charlene S Dezzutti
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

4.  Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences.

Authors:  M Zemba; A Alke; J Bodem; I G Winkler; R L Flower; K Pfrepper; H Delius; R M Flügel; M Löchelt
Journal:  Virology       Date:  2000-01-05       Impact factor: 3.616

5.  Genetic stability of foamy viruses: long-term study in an African green monkey population.

Authors:  M Schweizer; H Schleer; M Pietrek; J Liegibel; V Falcone; D Neumann-Haefelin
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

6.  Optimizing peptide matrices for identifying T-cell antigens.

Authors:  Melissa L Precopio; Tiffany R Butterfield; Joseph P Casazza; Susan J Little; Douglas D Richman; Richard A Koup; Mario Roederer
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

7.  New insights into prevalence, genetic diversity, and proviral load of human T-cell leukemia virus types 1 and 2 in pregnant women in Gabon in equatorial central Africa.

Authors:  Sonia Lekana-Douki Etenna; Mélanie Caron; Guillaume Besson; Maria Makuwa; Antoine Gessain; Antoine Mahé; Mirdad Kazanji
Journal:  J Clin Microbiol       Date:  2008-09-24       Impact factor: 5.948

8.  Clinical and virological characterization of persistent human infection with simian foamy viruses.

Authors:  Roumiana S Boneva; William M Switzer; Thomas J Spira; Vinod B Bhullar; Vedapuri Shanmugam; Mian-Er Cong; Lee Lam; Walid Heneine; Thomas M Folks; Louisa E Chapman
Journal:  AIDS Res Hum Retroviruses       Date:  2007-11       Impact factor: 2.205

9.  Simian foamy virus transmission from apes to humans, rural Cameroon.

Authors:  Sara Calattini; Edouard Betsem A Betsem; Alain Froment; Philippe Mauclère; Patricia Tortevoye; Christine Schmitt; Richard Njouom; Ali Saib; Antoine Gessain
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

10.  Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Peter D Burbelo; Elise Meoli; Hannah P Leahy; Jhanelle Graham; Karen Yao; Unsong Oh; John E Janik; Renaud Mahieux; Fatah Kashanchi; Michael J Iadarola; Steven Jacobson
Journal:  Retrovirology       Date:  2008-10-20       Impact factor: 4.602

View more
  2 in total

1.  Plasma antibodies from humans infected with zoonotic simian foamy virus do not inhibit cell-to-cell transmission of the virus despite binding to the surface of infected cells.

Authors:  Mathilde Couteaudier; Thomas Montange; Richard Njouom; Chanceline Bilounga-Ndongo; Antoine Gessain; Florence Buseyne
Journal:  PLoS Pathog       Date:  2022-05-23       Impact factor: 7.464

2.  Seroprevalence of Feline Foamy Virus in Domestic Cats in Poland.

Authors:  Magdalena Materniak-Kornas; Tadeusz Frymus; Martin Löchelt; Jacek Kuźmak
Journal:  J Vet Res       Date:  2021-10-29       Impact factor: 1.744

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.